Rate of serious infection in patients who are prescribed systemic biologic or nonbiologic agents for psoriasis: A large, single center, retrospective, observational cohort study.

about

Rate of serious infection in patients who are prescribed systemic biologic or nonbiologic agents for psoriasis: A large, single center, retrospective, observational cohort study.

Item

http://www.wikidata.org/entity/Q38630637

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Rate of serious infection in p ...... e, observational cohort study.

@en

type

Item

label

Rate of serious infection in p ...... e, observational cohort study.

@en

prefLabel

Rate of serious infection in p ...... e, observational cohort study.

@en

P1476

Rate of serious infection in p ...... e, observational cohort study.

@en

P2093

Aleksandra G Florek

http://www.w3.org/2001/XMLSchema#string

Chantelle Carneiro

http://www.w3.org/2001/XMLSchema#string

Dennis P West

http://www.w3.org/2001/XMLSchema#string

Erin Ibler

http://www.w3.org/2001/XMLSchema#string

Jennifer Day

http://www.w3.org/2001/XMLSchema#string

Kimberly A Sable

http://www.w3.org/2001/XMLSchema#string

Nicholas J Guido

http://www.w3.org/2001/XMLSchema#string

Romi Bloom

http://www.w3.org/2001/XMLSchema#string

Salvatore Nocadello

http://www.w3.org/2001/XMLSchema#string

Sara Majewski

http://www.w3.org/2001/XMLSchema#string

P2860

Enabling a Learning Health System through a Unified Enterprise Data Warehouse: The Experience of the Northwestern University Clinical and Translational Sciences (NUCATS) Institute

Long-term safety of biologics in the treatment of moderate-to-severe plaque psoriasis: review of current data.

Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials.

Efficacy and safety of tumor necrosis factor antagonists in Crohn's disease: meta-analysis of placebo-controlled trials.

The misperception that clinical trial data reflect long-term drug safety: lessons learned from Efalizumab's withdrawal.

Adverse Event Reporting in Clinical Trials of Finasteride for Androgenic Alopecia: A Meta-analysis.

Non-viral opportunistic infections in new users of tumour necrosis factor inhibitor therapy: results of the SAfety Assessment of Biologic ThERapy (SABER) study.

Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics.

Risk of hospitalised infection in rheumatoid arthritis patients receiving biologics following a previous infection while on treatment with anti-TNF therapy.

Drug safety of systemic treatments for psoriasis: results from The German Psoriasis Registry PsoBest.

P31

scholarly article

P356

10.1111/DTH.12529

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Beatrice Nardone

P577

2017-08-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28796405

http://www.w3.org/2001/XMLSchema#string